The
#AIEye: NICE (Nasdaq: $NICE) Expands Microsoft (Nasdaq: $MSFT) Collaboration
and Virtusa (Nasdaq: $VRTU) Announces “Life Sciences Competency” with AWS
(Nasdaq: $AMZN)
Global
Deep Learning in Machine Vision Market to Hit $997.27 Million by 2025
Point Roberts WA , Vancouver BC – July 15, 2019 – Investorideas.com (www.investorideas.com), a global investor news source covering
Artificial Intelligence (AI) brings you today’s edition of The
AI Eye- watching stock news, deal
tracker and advancements in artificial intelligence.
Listen
to today’s podcast:
Read
this in full at https://www.investorideas.com/news/2019/artificial-intelligence/07151AIEye-NICE-MSFT-VRTU-AMZN.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NasdaqGS:NICE) (NasdaqGS:MSFT) (NasdaqGS:VRTU) (NasdaqGS:AMZN)
NICE Ltd. (NasdaqGS:NICE) is expanding its collaboration with Microsoft (NasdaqGS:MSFT) across multiple platforms. As
part of this development, NICE Trading Recording, NICE inContact CXone and NICE
Multi Channel Recording will be integrated into the Microsoft Teams unified
communications platform. Chris Wooten, Executive Vice President of NICE
Vertical Markets, commented:
“The relationship that is developing between NICE and
Microsoft continues to be a success, so much so that it has expanded within the
NICE portfolio. At NICE, we deliver innovative technology that empowers organizations
to improve their customer experiences and ensure regulatory compliance.
Microsoft understands the value that our broad portfolio brings to the table
and has engaged with NICE to drive customer experience and compliance
initiatives all over the world.”
Virtusa Corporation (NasdaqGS:VRTU) has achieved Life Sciences Competency status with
Amazon (NasdaqGS:AMZN) subsidiary Amazon Web Services
(AWS). According to the press release, “Virtusa offers pre-built solutions,
AI/ML, and blockchain models to map patient journeys and disease progression”
and the company’s vLife platform is powered by AWS. Anthony Lange, senior vice
president, Life Sciences, Virtusa, said:
“Virtusa’s
Life Sciences practice leverages AWS to harness the power of data for improved
patient outcomes. Combining our deep life sciences expertise with powerful AWS
next generation technology capabilities, we build software that helps deliver
better patient outcomes at a lower cost. Achieving AWS Life Sciences Competency
status will help more Virtusa clients in the Life Sciences industry achieve
their business goals by leveraging the agility of AWS.”
Global
Deep Learning in Machine Vision Market to Hit $997.27 Million by 2025
A report from Data Bridge Market Research finds that the
global deep learning in machine vision market will grow to $997.27 million USD
by 2025. Within the market, image classification is projected to account for
the highest market share at 60.5 percent. An excerpt from the report
description reads:
There
is an increase in demand for deep learning software in various manufacturing
industries as the need for quality check and automation has increased.
Moreover, growth in adoption of cloud-based applications for storage of the
data is helping in the growth of the market. On the other hand lack of
technical expertise and absence of standard protocol for the manufacturing and
development of software and varying demand of end user has hindered the growth
of the market.
Sam Mowers,
Investorideas.com
For
a list of artificial intelligence stocks on Investorideas.com visit
here
or become an Investor Ideas member
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news and press releases plus we
create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts #Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change Podcast and the AI Eye Podcast and column covering
developments in AI.
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit
the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third
party sourced news, articles and equity research as well as creates original
content, including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions.
More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock
news, deal tracker and advancements in artificial intelligence is an
original content brand of Investorideas.com
Contact
Investorideas.com
800 665 0411